Geode Capital Management, LLC Abb Vie Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 37,494,653 shares of ABBV stock, worth $6.05 Billion. This represents 0.64% of its overall portfolio holdings.

Number of Shares

37,494,653

Previous 37,017,486 1.29%

Holding current value

$6.05 Billion

Previous $5.74 Billion 19.02%

% of portfolio

0.64%

Previous 0.61%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $76.3 Million - $86.9 Million	477,167 Added 1.29%	37,494,653 $6.83 Billion
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $111 Million - $126 Million	810,314 Added 2.24%	37,017,486 $5.74 Billion
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $168 Million - $194 Million	1,254,234 Added 3.59%	36,207,172 $5.4 Billion
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $120 Million - $150 Million	907,917 Added 2.67%	34,952,938 $4.71 Billion
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $42.3 Million - $48.7 Million	292,512 Added 0.87%	34,045,021 $5.43 Billion

Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $10.8 Million - $12.9 Million	-77,992 Reduced 0.23%	33,752,509 $5.45 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $503 Million - $577 Million	3,749,074 Added 12.46%	33,830,501 $4.54 Billion
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $187 Million - $238 Million	1,361,176 Added 4.74%	30,081,427 $4.6 Billion
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $26.6 Million - $33 Million	201,305 Added 0.71%	28,720,251 $4.64 Billion
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $81.5 Million - $103 Million	758,354 Added 2.73%	28,518,946 $3.85 Billion
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $54.9 Million - $62.3 Million	515,643 Added 1.89%	27,760,592 $2.99 Billion
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $1.3 Million - $1.45 Million	12,350 Added 0.05%	27,244,949 $3.06 Billion
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $56.3 Million - $62 Million	550,676 Added 2.06%	27,232,599 $2.94 Billion
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $44 Million - $59.4 Million	546,851 Added 2.09%	26,681,923 $2.85 Billion
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $243 Million - $285 Million	-2,823,520 Reduced 9.75%	26,135,072 $2.28 Billion
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $234 Million - $313 Million	3,185,087 Added 12.36%	28,958,592 $2.84 Billion
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $86.7 Million - $132 Million	1,344,728 Added 5.5%	25,773,505 $1.96 Billion
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $49.2 Million - $61.5 Million	681,783 Added 2.87%	24,428,777 $2.16 Billion
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $96 Million - $115 Million	1,524,799 Added 6.86%	23,746,994 $1.8 Billion
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $53.7 Million - $68.6 Million	817,407 Added 3.82%	22,222,195 $1.61 Billion
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $295 Million - $347 Million	3,822,261 Added 21.74%	21,404,788 $1.72 Billion
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $68.5 Million - $84.5 Million	880,288 Added 5.27%	17,582,527 $1.62 Billion
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $3.26 Million - $3.62 Million	36,620 Added 0.22%	16,702,239 $1.58 Billion
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $44.4 Million - $52.6 Million	-494,832 Reduced 2.88%	16,665,619 $1.54 Billion
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $103 Million - $138 Million	1,117,600 Added 6.97%	17,160,451 $1.62 Billion
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $62.4 Million - $68.5 Million	697,191 Added 4.54%	16,042,851 $1.55 Billion
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $22.4 Million - $28.7 Million	321,142 Added 2.14%	15,345,660 $1.36 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	15,024,518	15,024,518 $1.09 Billion

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Abb Vie Inc. Transaction History